Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 468

1.

Correction to: Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys.

Biggane AM, Brading L, Ravaud P, Young B, Williamson PR.

Trials. 2018 Aug 8;19(1):430. doi: 10.1186/s13063-018-2595-6.

2.

Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data.

Kwakkenbos L, Imran M, McCord KA, Sampson M, Fröbert O, Gale C, Hemkens LG, Langan SM, Moher D, Relton C, Zwarenstein M, Benchimol EI, Boutron I, Campbell MK, Erlinge D, Jawad S, Ravaud P, Rice DB, Sauve M, van Staa TP, Thabane L, Uher R, Verkooijen HM, Juszczak E, Thombs BD.

BMJ Open. 2018 Aug 5;8(8):e025266. doi: 10.1136/bmjopen-2018-025266.

3.

Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota: A Systematic Review.

Bafeta A, Koh M, Riveros C, Ravaud P.

Ann Intern Med. 2018 Jul 17. doi: 10.7326/M18-0343. [Epub ahead of print]

PMID:
30014150
4.

Avoidable waste of research related to outcome planning and reporting in clinical trials.

Yordanov Y, Dechartres A, Atal I, Tran VT, Boutron I, Crequit P, Ravaud P.

BMC Med. 2018 Jun 11;16(1):87. doi: 10.1186/s12916-018-1083-x.

5.

Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis.

Rivière E, Sellam J, Pascaud J, Ravaud P, Gottenberg JE, Mariette X.

Arthritis Res Ther. 2018 Jun 8;20(1):122. doi: 10.1186/s13075-018-1628-6.

6.

Mapping of Crowdsourcing in Health: Systematic Review.

Créquit P, Mansouri G, Benchoufi M, Vivot A, Ravaud P.

J Med Internet Res. 2018 May 15;20(5):e187. doi: 10.2196/jmir.9330. Review.

7.

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.

Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1150-1156. doi: 10.1136/annrheumdis-2017-212768. Epub 2018 May 3.

PMID:
29724729
8.

Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients.

Puéchal X, Iudici M, Calich AL, Vivot A, Terrier B, Régent A, Cohen P, Jeunne CL, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Rheumatology (Oxford). 2018 May 2. doi: 10.1093/rheumatology/key117. [Epub ahead of print]

PMID:
29722877
9.

Patients' perspectives on how to decrease the burden of treatment: a qualitative study of HIV care in sub-Saharan Africa.

Tran VT, Messou E, Mama Djima M, Ravaud P, Ekouevi DK.

BMJ Qual Saf. 2018 Apr 29. pii: bmjqs-2017-007564. doi: 10.1136/bmjqs-2017-007564. [Epub ahead of print]

10.

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. Epub 2018 Apr 25.

PMID:
29695500
11.

Patient-important outcomes in systematic reviews: Poor quality of evidence.

Yordanov Y, Dechartres A, Ravaud P.

PLoS One. 2018 Apr 5;13(4):e0195460. doi: 10.1371/journal.pone.0195460. eCollection 2018.

12.

Misrepresentation and distortion of research in biomedical literature.

Boutron I, Ravaud P.

Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2613-2619. doi: 10.1073/pnas.1710755115.

13.

Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy.

Freund R, Granger B, Francois C, Carcelain G, Ravaud P, Mariette X, Fautrel B.

Presse Med. 2018 Feb;47(2):e9-e13. doi: 10.1016/j.lpm.2017.09.029. Epub 2018 Feb 23.

PMID:
29478790
14.

Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys.

Biggane AM, Brading L, Ravaud P, Young B, Williamson PR.

Trials. 2018 Feb 17;19(1):113. doi: 10.1186/s13063-018-2493-y. Erratum in: Trials. 2018 Aug 8;19(1):430.

15.

Factors associated with online media attention to research: a cohort study of articles evaluating cancer treatments.

Haneef R, Ravaud P, Baron G, Ghosn L, Boutron I.

Res Integr Peer Rev. 2017 Jul 1;2:9. doi: 10.1186/s41073-017-0033-z. eCollection 2017.

16.

Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis.

Zeitoun JD, Ross JS, Atal I, Vivot A, Downing NS, Baron G, Ravaud P.

Clin Pharmacol Ther. 2018 Jan 29. doi: 10.1002/cpt.1038. [Epub ahead of print]

PMID:
29377075
17.

A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non-high-income regions.

Atal I, Trinquart L, Ravaud P, Porcher R.

J Clin Epidemiol. 2018 Jun;98:123-132. doi: 10.1016/j.jclinepi.2018.01.006. Epub 2018 Jan 31.

PMID:
29360559
18.
19.

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study.

Zeitoun JD, Ross JS, Atal I, Vivot A, Downing NS, Baron G, Ravaud P.

BMJ Open. 2017 Dec 21;7(12):e018587. doi: 10.1136/bmjopen-2017-018587.

20.

The Association Between Fibroblast Growth Factor 23 and Renal Transplantation Outcome Is Modified by Follow-up Duration and Glomerular Filtration Rate Assessment Method.

Bienaimé F, Dechartres A, Anglicheau D, Sabbah L, Montgermont P, Friedlander G, Ravaud P, Legendre C, Prié D.

Kidney Int Rep. 2017 May 18;2(5):881-892. doi: 10.1016/j.ekir.2017.05.007. eCollection 2017 Sep.

21.

Sharing and reuse of individual participant data from clinical trials: principles and recommendations.

Ohmann C, Banzi R, Canham S, Battaglia S, Matei M, Ariyo C, Becnel L, Bierer B, Bowers S, Clivio L, Dias M, Druml C, Faure H, Fenner M, Galvez J, Ghersi D, Gluud C, Groves T, Houston P, Karam G, Kalra D, Knowles RL, Krleža-Jerić K, Kubiak C, Kuchinke W, Kush R, Lukkarinen A, Marques PS, Newbigging A, O'Callaghan J, Ravaud P, Schlünder I, Shanahan D, Sitter H, Spalding D, Tudur-Smith C, van Reusel P, van Veen EB, Visser GR, Wilson J, Demotes-Mainard J.

BMJ Open. 2017 Dec 14;7(12):e018647. doi: 10.1136/bmjopen-2017-018647.

22.

Node-making process in network meta-analysis of nonpharmacological treatment are poorly reported.

James A, Yavchitz A, Ravaud P, Boutron I.

J Clin Epidemiol. 2018 May;97:95-102. doi: 10.1016/j.jclinepi.2017.11.018. Epub 2017 Nov 28.

PMID:
29196202
23.

Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registry.

Nourisson C, Soubrier M, Mulliez A, Baillet A, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Schaeverbeke T, Sibilia J, Vittecoq O, Ravaud P, Gottenberg JE, Mariette X, Tournadre A.

RMD Open. 2017 Nov 1;3(2):e000515. doi: 10.1136/rmdopen-2017-000515. eCollection 2017.

24.

Interpretation of health news items reported with or without spin: protocol for a prospective meta-analysis of 16 randomised controlled trials.

Haneef R, Yavchitz A, Ravaud P, Baron G, Oransky I, Schwitzer G, Boutron I.

BMJ Open. 2017 Nov 17;7(11):e017425. doi: 10.1136/bmjopen-2017-017425.

25.

Dissemination of 2014 dual antiplatelet therapy (DAPT) trial results: a systematic review of scholarly and media attention over 7 months.

Sharp MK, Haneef R, Ravaud P, Boutron I.

BMJ Open. 2017 Nov 3;7(11):e014503. doi: 10.1136/bmjopen-2016-014503. Review.

26.

Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis.

Créquit P, Chaimani A, Yavchitz A, Attiche N, Cadranel J, Trinquart L, Ravaud P.

BMC Med. 2017 Oct 30;15(1):193. doi: 10.1186/s12916-017-0954-x. Review.

27.

Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.

Salmon JH, Perotin JM, Morel J, Dramé M, Cantagrel A, Ziegler LE, Ravaud P, Sibilia J, Pane I, Mariette X, Gottenberg JE; French Society of Rheumatology.

Rheumatology (Oxford). 2018 Jan 1;57(1):134-139. doi: 10.1093/rheumatology/kex403.

PMID:
29069471
28.

Evaluating alternative systems of peer review: a large-scale agent-based modelling approach to scientific publication.

Kovanis M, Trinquart L, Ravaud P, Porcher R.

Scientometrics. 2017;113(1):651-671. doi: 10.1007/s11192-017-2375-1. Epub 2017 Apr 3.

29.

Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE.

Morel J, Constantin A, Baron G, Dernis E, Flipo RM, Rist S, Combe B, Gottenberg JE, Schaeverbeke T, Soubrier M, Vittecoq O, Dougados M, Saraux A, Mariette X, Ravaud P, Sibilia J.

Rheumatology (Oxford). 2017 Oct 1;56(10):1746-1754. doi: 10.1093/rheumatology/kex238.

PMID:
28957557
30.

Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.

Zeitoun JD, Baron G, Vivot A, Atal I, Downing NS, Ross JS, Ravaud P.

Int J Cancer. 2018 Jan 15;142(2):414-423. doi: 10.1002/ijc.31061. Epub 2017 Oct 12.

PMID:
28929484
31.

A protocol of a cross-sectional study evaluating an online tool for early career peer reviewers assessing reports of randomised controlled trials.

Chauvin A, Moher D, Altman D, Schriger DL, Alam S, Hopewell S, Shanahan DR, Recchioni A, Ravaud P, Boutron I.

BMJ Open. 2017 Sep 15;7(9):e017462. doi: 10.1136/bmjopen-2017-017462.

32.

Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus.

Morel N, Lévesque K, Maltret A, Baron G, Hamidou M, Orquevaux P, Piette JC, Barriere F, Le Bidois J, Fermont L, Fain O, Theulin A, Sassolas F, Hauet Q, Guettrot-Imbert G, Georgin-Lavialle S, Deligny C, Hachulla E, Mouthon L, Le Jeunne C, Ravaud P, Le Mercier D, Romefort B, Villain E, Bonnet D, Costedoat-Chalumeau N; “Lupus néonatal” group.

Int J Cardiol. 2017 Dec 1;248:263-269. doi: 10.1016/j.ijcard.2017.07.100. Epub 2017 Aug 7.

PMID:
28843719
33.

Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker Testing.

Vivot A, Boutron I, Béraud-Chaulet G, Zeitoun JD, Ravaud P, Porcher R.

Sci Rep. 2017 Jul 31;7(1):6882. doi: 10.1038/s41598-017-07358-7.

34.

Enhancing the usability of systematic reviews by improving the consideration and description of interventions.

Hoffmann TC, Oxman AD, Ioannidis JP, Moher D, Lasserson TJ, Tovey DI, Stein K, Sutcliffe K, Ravaud P, Altman DG, Perera R, Glasziou P.

BMJ. 2017 Jul 20;358:j2998. doi: 10.1136/bmj.j2998. No abstract available.

PMID:
28729459
35.

Blockchain technology for improving clinical research quality.

Benchoufi M, Ravaud P.

Trials. 2017 Jul 19;18(1):335. doi: 10.1186/s13063-017-2035-z.

36.

Socioeconomic Deprivation and Utilization of Anesthetic Care During Pregnancy and Delivery: A Secondary Analysis of a French Prospective, Multicenter, Cohort Study.

Kantor E, Guglielminotti J, Azria E, Luton D, Laurent M, Oury JF, Mahieu-Caputo D, Ravaud P, Estellat C; PreCARE Study Group.

Anesth Analg. 2017 Sep;125(3):925-933. doi: 10.1213/ANE.0000000000002275. Erratum in: Anesth Analg. 2017 Dec;125(6):2172.

PMID:
28708666
37.

Protocol for a systematic review of N-of-1 trial protocol guidelines and protocol reporting guidelines.

Porcino AJ, Punja S, Chan AW, Kravitz R, Orkin A, Ravaud P, Schmid CH, Vohra S.

Syst Rev. 2017 Jul 6;6(1):132. doi: 10.1186/s13643-017-0525-4. Review.

38.

Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.

Puéchal X, Pagnoux C, Baron G, Quémeneur T, Néel A, Agard C, Lifermann F, Liozon E, Ruivard M, Godmer P, Limal N, Mékinian A, Papo T, Ruppert AM, Bourgarit A, Bienvenu B, Geffray L, Saraux JL, Diot E, Crestani B, Delbrel X, Sailler L, Cohen P, Le Guern V, Terrier B, Groh M, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2017 Nov;69(11):2175-2186. doi: 10.1002/art.40205. Epub 2017 Oct 15.

PMID:
28678392
39.

Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa.

Ndounga Diakou LA, Ntoumi F, Ravaud P, Boutron I.

Trials. 2017 Jul 5;18(1):291. doi: 10.1186/s13063-017-2034-0. Review. Erratum in: Trials. 2018 Jan 16;19(1):42.

40.

CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.

Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P; CONSORT NPT Group.

Ann Intern Med. 2017 Jul 4;167(1):40-47. doi: 10.7326/M17-0046. Epub 2017 Jun 20.

PMID:
28630973
41.

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study.

Dechartres A, Trinquart L, Atal I, Moher D, Dickersin K, Boutron I, Perrodeau E, Altman DG, Ravaud P.

BMJ. 2017 Jun 8;357:j2490. doi: 10.1136/bmj.j2490. Erratum in: BMJ. 2017 Aug 8;358:j3806.

PMID:
28596181
42.

Methods and Reporting Studies Assessing Fecal Microbiota Transplantation: A Systematic Review.

Bafeta A, Yavchitz A, Riveros C, Batista R, Ravaud P.

Ann Intern Med. 2017 Jul 4;167(1):34-39. doi: 10.7326/M16-2810. Epub 2017 May 23. Review.

PMID:
28531908
43.

Association between maternal social deprivation and prenatal care utilization: the PreCARE cohort study.

Gonthier C, Estellat C, Deneux-Tharaux C, Blondel B, Alfaiate T, Schmitz T, Oury JF, Mandelbrot L, Luton D, Ravaud P, Azria E.

BMC Pregnancy Childbirth. 2017 May 16;17(1):126. doi: 10.1186/s12884-017-1310-z.

44.

Dosage of Preventive or Therapeutic Exercise Interventions: Review of Published Randomized Controlled Trials and Survey of Authors.

Gallois M, Davergne T, Ledinot P, Ravaud P, Regnaux JP.

Arch Phys Med Rehabil. 2017 Dec;98(12):2558-2565.e10. doi: 10.1016/j.apmr.2017.03.030. Epub 2017 Apr 30. Review.

PMID:
28465221
45.

Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000-2015.

Vivot A, Jacot J, Zeitoun JD, Ravaud P, Crequit P, Porcher R.

Ann Oncol. 2017 May 1;28(5):1111-1116. doi: 10.1093/annonc/mdx053.

PMID:
28453694
46.

Differences in Treatment Effect Size Between Overall Survival and Progression-Free Survival in Immunotherapy Trials: A Meta-Epidemiologic Study of Trials With Results Posted at ClinicalTrials.gov.

Tan A, Porcher R, Crequit P, Ravaud P, Dechartres A.

J Clin Oncol. 2017 May 20;35(15):1686-1694. doi: 10.1200/JCO.2016.71.2109. Epub 2017 Apr 4.

PMID:
28375786
47.

Intradiscal Glucocorticoid Injection for Patients With Chronic Low Back Pain Associated With Active Discopathy: A Randomized Trial.

Nguyen C, Boutron I, Baron G, Sanchez K, Palazzo C, Benchimol R, Paris G, James-Belin É, Lefèvre-Colau MM, Beaudreuil J, Laredo JD, Béra-Louville A, Cotten A, Drapé JL, Feydy A, Ravaud P, Rannou F, Poiraudeau S.

Ann Intern Med. 2017 Apr 18;166(8):547-556. doi: 10.7326/M16-1700. Epub 2017 Mar 21.

PMID:
28319997
48.
49.

Systematic reviews of therapeutic interventions frequently consider patient-important outcomes.

Ameur H, Ravaud P, Fayard F, Riveros C, Dechartres A.

J Clin Epidemiol. 2017 Apr;84:70-77. doi: 10.1016/j.jclinepi.2017.01.006. Epub 2017 Jan 29. Review.

PMID:
28147235
50.

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M; MONALISA study group.

Lancet Infect Dis. 2017 May;17(5):510-519. doi: 10.1016/S1473-3099(16)30521-7. Epub 2017 Jan 28.

Supplemental Content

Loading ...
Support Center